Immunovia AB (publ) (IMMNOV.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -381.91%; 2025 (actual)
ROA: -240.68%; 2025 (actual)
Gross Margin: 80.15%; 2025 (actual)
Net Margin: -
Total Assets: SEK 88,212.00K; 2025 (actual)
Net Income: -SEK 145,915.00K; 2025 (actual)
Valuation: SEK 152,695.38K; 2026 (forecast)
Stock Price: SEK 0.23; 2026 (forecast)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026 (forecast)	2027	2028	2029	2030	2031
ROE	-381.91%	-544.19%	255.63%	77.8%	49.24%	35.58%	27.69%
ROA	-240.68%	-353.08%	-713.43%	-	-	-	-
Gross Margin	80.15%	64.17%	64.17%	64.17%	64.17%	64.17%	64.17%
Sector average	-	17.71%	17.71%	17.71%	17.71%	17.71%	62.35%
Total Assets	SEK 88,212.00K

Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.

Want the full financial forecast report for Immunovia AB (publ)? It covers the balance sheet, income statement and Equlion model projections.

Net Income	-SEK 145,915.00K	-SEK 240,530.23K	-SEK 217,221.99K	-SEK 246,522.43K	-SEK 287,462.91K	-SEK 314,864.97K	-SEK 335,057.66K
Sector average	-	-SEK 22,027.28K	-SEK 904.69K	-SEK 7,253.84K	-SEK 3,858.45K	-SEK 1,547.00K	-SEK 13,704.11K

Valuation	-	SEK 152,695.38K	SEK 137,898.65K	SEK 156,499.40K	SEK 182,489.57K	SEK 199,885.17K	SEK 212,704.06K
Sector average	-	SEK 5,151,301.60K	SEK 5,189,236.02K	SEK 5,317,343.69K	SEK 5,514,329.75K	SEK 5,636,782.17K	SEK 3,179,755.44K

Stock Price	-	SEK 0.23	SEK 0.21	SEK 0.23	SEK 0.27	SEK 0.30	SEK 0.32
Sector average	-	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41	SEK 36.70